Kiyofumi Sasai

Randomized, double‐blind, placebo‐controlled study to assess the efficacy and safety of vortioxetine in Japanese patients with major depressive disorder

Takeshi Inoue, Kiyofumi Sasai, T Kitagawa et al. · Psychiatry and Clinical Neurosciences · 2019 · 47 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +14

Randomized, double‐blind, placebo‐controlled 8‐week trial of the efficacy, safety, and tolerability of 5, 10, and 20 mg/day vortioxetine in adults with major depressive disorder

Akira Nishimura, Yutaka Aritomi, Kiyofumi Sasai et al. · Psychiatry and Clinical Neurosciences · 2017 · 46 citations · Full text

Medicine, Pharmacology, Psychiatry +17

Randomized, 8‐week, double‐blind, placebo‐controlled trial of vortioxetine in Japanese adults with major depressive disorder, followed by a 52‐week open‐label extension trial

Takeshi Inoue, Akira Nishimura, Kiyofumi Sasai et al. · Psychiatry and Clinical Neurosciences · 2017 · 27 citations · Full text

Medicine, Pharmacology, Psychiatry +17

A randomized controlled study evaluating safety and efficacy of leuprorelin acetate every-3-months depot for 2 versus 3 or more years with tamoxifen for 5 years as adjuvant treatment in premenopausal patients with endocrine-responsive breast cancer

Eiichi Shiba, Hiroko Yamashita, Junichi Kurebayashi et al. · Breast Cancer · 2015 · 17 citations · Full text

Medicine, Endocrinology, Oncology +15

Evaluation of the Efficacy and Tolerability of Combination Therapy With Candesartan Cilexetil and Amlodipine Besilate Compared With Candesartan Cilexetil Monotherapy and Amlodipine Besilate Monotherapy in Japanese Patients With Mild-to-Moderate Essential Hypertension: A Multicenter, 12-Week, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study

Hiromi Rakugi, Toshio Ogihara, Yuko Miyata et al. · Clinical Therapeutics · 2012 · 11 citations

Pharmacy, Pharmacology, Pharmacotherapy +12